Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Pierre Peterlin

20PUBLICATIONS

103CO-AUTHORS

Haematological tumoursMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyHaematology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Feb 11, 2026

Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.

Gaspar Aspas Requena, Pau Montesinos, Emilie Bérard

|Sep 25, 2025

Ziftomenib in Relapsed or Refractory <i>NPM1</i>-Mutated AML.

Eunice S Wang, Pau Montesinos, James Foran

|Aug 18, 2025

Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial.

Uwe Platzbecker, Lionel Adès, Pau Montesinos

|Dec 19, 2024

Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm.

Stéphane De Botton, Christian Récher, Jorge Cortes

|Jun 20, 2024

Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment.

Sylvain Garciaz, Pierre-Yves Dumas, Sarah Bertoli

|Apr 13, 2024

Late Relapse after Allogeneic Stem Cell Transplantation in Patients Treated for Acute Myeloid Leukemia: Relapse Incidence, Characteristics, Role of Conditioning Regimen, and Outcome.

Chloé Antier, Maxime Jullien, Benoît Tessoulin

Pageof 4

Frequent Collaborators

8 joint publications

Patrice Chevallier

6 joint publications

Thierry Guillaume

5 joint publications

Maxime Jullien

4 joint publications

Philippe Moreau

4 joint publications

Marion Eveillard

3 joint publications

Pau Montesinos

3 joint publications

Benoît Tessoulin

3 joint publications

Pierre Fenaux

3 joint publications

Christian Recher

2 joint publications

Thomas Cluzeau

Frequent Collaborators

8 joint publications

Patrice Chevallier

6 joint publications

Thierry Guillaume

5 joint publications

Maxime Jullien

4 joint publications

Philippe Moreau

Top Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on : Jun 06, 2025

See more related videos

Top Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on : Jun 06, 2025

See more related videos